Today: 10 June 2026
PBF Energy stock jumps 4% to end 2025 as EIA fuel builds hit refiners’ radar
1 January 2026
2 mins read

PBF Energy stock jumps 4% to end 2025 as EIA fuel builds hit refiners’ radar

NEW YORK, January 1, 2026, 07:31 ET — Market closed

  • PBF Energy shares last closed up 4.15% on Dec. 31, while U.S. markets are shut Thursday for the New Year’s Day holiday.
  • Fresh EIA data showed crude inventories fell, but gasoline and distillate stocks surged on strong refinery runs.
  • Investors’ next focus includes PBF’s Goldman Sachs conference appearance (Jan. 5–7) and its Feb. 12 earnings report.

PBF Energy Inc shares finished the last U.S. trading session up more than 4%, outperforming larger refiners as investors parsed new U.S. fuel inventory data into year-end. U.S. markets are closed on Thursday for the New Year’s Day holiday.

The move matters now because refiners’ earnings swing with the crack spread — the gap between crude oil costs and prices for fuels such as gasoline and diesel. That spread has been whipsawed by weekly supply-and-demand signals and shifting expectations for early-2026 consumption.

Traders also had one eye on 2025’s sharp drop in crude prices, which can lower a refiner’s feedstock bill. But bigger fuel inventories can still pinch margins if gasoline and diesel prices soften.

PBF ended Wednesday at $27.12, up 4.15%, after trading between $25.65 and $27.51; shares were up 0.44% in late after-hours deals. The stock’s 52-week range is $13.62 to $41.48, and volume of about 2.15 million shares ran below its recent average, data showed.

Bigger U.S. refiners were weaker on the day, with Valero Energy, Marathon Petroleum and Phillips 66 all closing lower, highlighting PBF’s outperformance.

In the week ended Dec. 26, U.S. commercial crude inventories excluding the Strategic Petroleum Reserve fell 1.9 million barrels to 422.9 million, the Energy Information Administration said. Gasoline stocks rose 5.8 million barrels and distillate inventories rose 5.0 million barrels, while refineries ran at 94.7% of operable capacity and total petroleum inventories increased 10.2 million barrels.

“Year end numbers tend to be distorted,” said Josh Young, chief investment officer at Bison Interests. He said shifts tied to ad valorem taxes — levies based on the value of stored oil — can blur the margin signal in weekly data. Reuters

Oil’s broader backdrop remained bearish heading into 2026, with Brent down nearly 18% in 2025 and U.S. West Texas Intermediate down about 19% on oversupply worries, a Reuters report said. That mix can help refiners on crude costs while leaving them vulnerable if product prices weaken.

The EIA’s latest Short-Term Energy Outlook forecasts Brent averaging about $55 a barrel in the first quarter of 2026 and expects lower U.S. crack spreads in December and early 2026 versus its prior forecast. It still sees refinery margins running higher on average in 2026, helped by lower crude prices and tightness in some product markets.

PBF said its management team will participate in the Goldman Sachs Energy, CleanTech & Utilities Conference on Jan. 5–7. The company operates refineries in California, Delaware, Louisiana, New Jersey and Ohio and is a 50% partner in the St. Bernard Renewables joint venture, it said.

The company said it will release fourth-quarter 2025 results on Feb. 12, with a conference call and webcast scheduled for 8:30 a.m. ET. Investors will look for updates on utilization, planned maintenance and how margins tracked into the end of the year.

Before the next session on Friday, traders are likely to keep focusing on crack spreads and product stockpiles — inputs that can move refiners quickly when they surprise. The EIA’s Weekly Petroleum Status Report is normally released at 10:30 a.m. Eastern time on Wednesdays, with timing adjusted for federal holidays.

On the chart, traders will watch whether PBF can hold above $25.65, Wednesday’s low, after failing to push past $27.51, the day’s high. Longer term, the shares remain well off the 52-week high of $41.48 and above the 52-week low of $13.62.

Stock Market Today

  • TSMC Reports Record May Sales Amid AI-Driven Demand, Shares Decline
    June 10, 2026, 9:18 AM EDT. TSMC reported record May sales of NT$416.98 billion, up 30.1% year-on-year and 1.5% from April, signaling robust demand largely driven by AI chip production. Despite this, TSMC shares fell 2.17% on the Taiwan Stock Exchange, with U.S.-listed ADRs also down 3.85% in premarket trading reflecting investor concerns about the company's ability to expand capacity without impacting margins or encountering supply chain and geopolitical challenges. CEO C.C. Wei acknowledged the strain on capacity amid strong customer demand. The company's first five months' revenue rose 30% to NT$1.962 trillion, aligning with TSMC's Q2 revenue forecast of $39.0-$40.2 billion and a gross margin target of 65.5%-67.5%. The report highlights enduring optimism tempered by operational challenges in scaling AI chip production.

Latest articles

PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop